Precise Oncology

Precise Oncology Solutions is a comprehensive molecular diagnostic platform developed by Myriad Genetics to streamline the delivery of genetic and genomic insights for cancer treatment. The suite integrates germline testing (MyRisk), tumor profiling (Precise Tumor), and companion diagnostics (BRACAnalysis CDx, MyChoice CDx) into a single ordering workflow and unified report. By combining hereditary risk assessment with somatic mutation analysis, the platform enables oncologists to identify targeted therapy eligibility, such as for PARP inhibitors, and match patients to clinical trials. The solution is supported by the Precise Treatment Registry, which utilizes de-identified data to advance precision medicine research and improve patient outcomes across solid tumor indications.